ng-nitroarginine methyl ester has been researched along with Cardiomyopathy, Hypertrophic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coelho-Filho, OR; Das, S; Jerosch-Herold, M; Kwong, R; Mitchell, R; Moreno, H; Neilan, TG; Rosenzweig, A; Shah, RV; Simonson, B | 1 |
| Franchini, KG; Hyslop, S; Luca, IM; Melo, SE; Moreno, H; Sampaio, RC; Tanus-Santos, JE | 1 |
| Deblois, D; Girardot, D; Jover, B; Moles, JP; Moreau, P | 1 |
| Balligand, JL; Dessy, C; Donckier, J; Feron, O; Havaux, X; Massart, PE; Morel, N; Piech, A; Vanoverschelde, JL | 1 |
4 other study(ies) available for ng-nitroarginine methyl ester and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Quantification of cardiomyocyte hypertrophy by cardiac magnetic resonance: implications for early cardiac remodeling.
Topics: Algorithms; Animals; Aortic Valve Stenosis; Biomarkers; Body Water; Cardiomyopathy, Hypertrophic; Cell Size; Contrast Media; Gadolinium DTPA; Hypertension; Hypertrophy; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Mice; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Phenotype; Random Allocation; Ventricular Remodeling | 2013 |
Hypertension plus diabetes mimics the cardiomyopathy induced by nitric oxide inhibition in rats.
Topics: Analysis of Variance; Animals; Blotting, Western; Cardiomyopathy, Hypertrophic; Diabetes Mellitus, Experimental; Disease Models, Animal; Hypertension, Renovascular; Immunohistochemistry; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Probability; Random Allocation; Rats; Rats, Wistar; Streptozocin | 2002 |
Chronic nitric oxide synthase inhibition prevents new coronary capillary generation.
Topics: Administration, Oral; Animals; Aorta; Blood Pressure; Body Mass Index; Body Weight; Capillaries; Cardiac Volume; Cardiomyopathy, Hypertrophic; Coronary Vessels; Drug Administration Schedule; Drug Therapy, Combination; Heart; Heart Ventricles; Male; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Organ Size; Penicillamine; Rats; Rats, Wistar; Ventricular Remodeling | 2004 |
Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy.
Topics: Animals; Cardiomyopathy, Hypertrophic; Caveolin 1; Caveolins; Coronary Circulation; Disease Models, Animal; Dogs; Echocardiography; Hemodynamics; Hypertension, Renal; Immunoblotting; Immunohistochemistry; Mesenteric Arteries; Microcirculation; Muscle Contraction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Regression Analysis; Ventricular Function, Left | 2002 |